For the Inventor, By the Inventor

Enter assignee name

Providence, RI, United States of America

Epivax, Inc.

USPTO Granted Patents = 22

% Expired Patents = 45.5

CIPO Patents = 1

EPO Patents = 8

Trademarks = 8

Forward Citations = 88

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

William Martin (19 out of 28 patents)

Anne Searls De Groot (18 out of 18 patents)

Daniel S Rivera (15 out of 16 patents)

4. Daniel Hoft (2 out of 3 patents)

5. Annie De Groot (2 out of 3 patents)

6. Amy S Rosenberg (2 out of 2 patents)

7. Chris Eickhoff (1 out of 1 patent)

8. Mark C Poznansky (1 out of 32 patents)

9. Anja Garritsen (1 out of 2 patents)

10. Anja Scholzen (1 out of 1 patent)

11. Leonard Jeffrey Moise (1 out of 1 patent)

12. Timothy Alan Brauns (1 out of 5 patents)

13. Ann Elizabeth Sluder (1 out of 1 patent)

14. Christopher S Eickhoff (1 out of 1 patent)

15. William D Martin (0 patent)

22 patents: Sort by Forward Citations

1. 12275956 - Regulatory T cell epitopes (2025-04-14),

2. 12247053 - Peptides for inducing heterosubtypic influenza T cell responses (2025-03-11),

3. 12016909 - Regulatory T cell epitopes, compositions and uses thereof (2024-06-25),

4. 11911414 - Regulatory T cell epitopes (2024-02-27),

5. 11844826 - Regulatory T cell epitopes, compositions and uses thereof (2023-12-19),

6. 11690902 - epitopes for T cell-targeted Q fever vaccines (2023-07-04),

7. 11441122 - Regulatory T cell epitopes (2022-09-13),

8. 11045532 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),

9. 11045531 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),

10. 11045530 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),

11. 11045529 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),

12. 11045528 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),

13. 10980867 - Regulatory T cell epitopes, compositions and uses thereof (2021-04-20),

14. 10925942 - Regulatory T cell epitopes, compositions and uses thereof (2021-02-23),

15. 10925941 - Regulatory T cell epitopes, compositions and uses thereof (2021-02-23),

EpiVax, Inc. is a biotechnology company located in Providence, Rhode Island. They specialize in developing and applying computational immunology tools and algorithms to facilitate the design of new vaccines and immunotherapies. With over two decades of experience, EpiVax has become a leader in the field, providing innovative solutions for the prevention and treatment of infectious diseases and autoimmune disorders. Their expertise also extends to personalized medicine and regulatory compliance. Visit their website to learn more about their cutting-edge research and collaborations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

22 Patents

#19 in Providence, RI

#75 in Rhode Island

#15,008 in US

#28,704 in the World

Providence, RI, United States of America

Epivax, Inc.

Forward Citations = 88

14 inventors:

William Martin (19 out of 28 patents)

Anne Searls De Groot (18 out of 18 patents)

Daniel S Rivera (15 out of 16 patents)

4. Daniel Hoft (2 out of 3 patents)

5. Annie De Groot (2 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…